Official Title
Changing of PSA With Covid-19
Brief Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a worldwide pandemic in over 100 years. The disease caused by this newly discovered virus was called Covid-19. In this study, we aimed to evaluate changing of PSA value in patients with Covid-19.

Detailed Description

Patients with positive PCR test results were included in the study. The age of the patient
and urea, leukocyte, hemoglobin, platelet, urea, and creatinine values of the patients were
recorded. Urinalysis and urine culture were taken from all patients. Acute phase reactants
such as sedimentation, C-reaktif protein (CRP), ferritin, and fibrinogen were measured both
at the time the patients applied and three weeks after the patient recovered. PSA and free
PSA were also measured in the same way. Patients whose symptoms improved and the PCR test
result was negative were considered as recovered.

Recruiting
COVID19
Prostate Specific Antigen

Other: PSA value

We measure PSA value during and after covid-19 infection

Eligibility Criteria

Inclusion Criteria:

- Male patients (>45 and <70 years of age) positive PCR test results were included in
the study

Exclusion Criteria:

- The patients <45 and >70 years of age who described lower urinary tract symptoms who
had urinary tract infection who a history of prostate biopsy and previous high level
of PSA who history of prostatitis were excluded.

Eligibility Gender
Male
Eligibility Age
Minimum: 45 Years ~ Maximum: 70 Years
Countries
Turkey
Locations

Omer Gokhan Doluoglu
Ankara, Altindag, Turkey

Investigator: Omer G Doluoglu
Contact: +905332157809
drdoluoglu@yahoo.com.tr

Contacts

Omer G Doluoglu, Associate Professor
+905332157809
drdoluoglu@yahoo.com.tr

Omer G Doluoglu, Associate Professor, Principal Investigator
Ankara Training and Research Hospital

Saglik Bilimleri Universitesi
NCT Number
Keywords
Covid-19
prostate cancer
Prostate Specific Antigen
MeSH Terms
COVID-19